Companies: 10,795·Total market cap: $144.5T

Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd.

DRTSNASDAQHealthcare● Active

$9.28

$-0.07(-0.75%)

Market Cap$838224129

P/E Ratio—

52W High$11.62

52W Low$2.85

Avg Volume612K

Open$9.58

Beta1.20

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Alpha Tau Medical Ltd.（DRTS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · DRTS · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.67Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding80.6MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Alpha Tau Medical Ltd. 数据

分析师预测$13 · Buy

股息不分红

盈利EPS $-0.53-17.78%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$42.6M▼ 34.26% YoY

202320242025

FY 2025EPS$-0.53▼ 17.78% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$56.9MEPS: $-0.67View income statement →

分析师评级与目标价

Buy6 位分析师

Strong Buy

0

Buy

5

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$8.00Low

$9.28Current

$13.33Avg Target上涨空间 43.64%

$17.00High

合计: 6 · 买入占比: 83.3%

根据过去 3 个月内 6 位华尔街分析师，DRTS 共识评级为 Buy，12 个月平均目标价 $13.33 （较现价 $9.28 上涨空间 43.64%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Alpha Tau Medical Ltd.

$9.28-0.75%$838.2M #2

$2.19-2.67%$222.9M #3

Aldeyra Therapeutics, Inc.

$1.74+6.75%$105.0M #4

Amarin Corporation plc

$14.20+1.94%$293.7M #5

Alto Neuroscience, Inc.

$18.24-0.11%$640.1M #6

Candel Therapeutics, Inc.

$8.50-0.12%$466.7M

股票表现

1D-0.75%

1W+0.11%

1M+9.05%

3M+44.77%

YTD+87.47%

1Y+196.49%

5Y-3.93%

关于 Alpha Tau Medical Ltd.

CEOUzi Sofer

IPO DateMar 8, 2021

Employees125

CountryIL

Websitealphatau.com

Alpha Tau Medical Ltd. is a clinical-stage biotechnology company dedicated to the advancement and eventual commercialization of innovative cancer treatments. Their primary focus is on "Alpha DaRT" (Di…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

Alpha Tau Medical Ltd.（DRTS）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 8, 2021 在 NASDAQ 上市。截至最近交易日，DRTS 股价为 $9.28，市值约为 $838.2M。过去12个月累计回报 +196.49%，年初至今回报 +87.47%。

根据 6 位华尔街分析师，Alpha Tau Medical Ltd. 股票共识评级为Buy，12个月平均目标价为 $13.33。2025 财年 Alpha Tau Medical Ltd. 营收 —，净利润 -$42.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Alpha Tau Medical Ltd.（DRTS）股价为 $9.28，在 NASDAQ 上市，52周区间为 $2.85 – $11.62。

DRTS 最新股价DRTS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议